
General Infertility Terms
Pelvic pain Menopause PMS Infertility Recurrent Pregnancy Loss Prolactin Polycystic Ovaries Pelvic SurgeryEndometriosis Fibroids Reversal of Tubal Ligation Ectopic Pregnancy Multiple Gestation Endometrial Polyps Preimplantation Genetic Diagnosis (PGD)
 	Pelvic pain is a common complaint. Its nature and intensity may fluctuate,  	and its cause is often obscure and in some cases no disease can be shown.  	Pelvic pain may originate from common sites such as the uterus, tubes, and  	ovaries, or in less common sites. At times, the pain may psychogenic, or at  	least related to emotional states. To diagnosis the causes of and prescribe  	treatment for pelvic pain, physicians conduct a thorough personal and  	medical history, with special attention to: type of discomfort, distribution  	and radiation of pain, duration of pain, associated symptoms, and relation  	to urination, bowel movements, and sexual intercourse. Particularly  	important is the relationship to the menstrual cycle. Pelvic pain may have  	multiple causes, including inflammation or direct irritation of nerves  	caused by adhesions or scar tissue. Appropriate management of pelvic pain  	ranges from conservative or medical management (including hormonal  	treatments and pain killers) to surgical management (often including  	laparoscopy). A thorough evaluation and directed treatment by a trained  	physician will relief pain in over 80% of women.
 	Menopause is the medical term for the end of a woman's menstrual periods. It  	is a natural part of aging, and occurs when the ovaries stop making hormones  	called estrogens. This causes estrogen levels to drop, and leads to the end  	of monthly menstrual periods. The average age of menopause is 51, but it can  	also occur when the ovaries are surgically removed or stop functioning  	earlier. 
 	Declining estrogen levels are linked to some uncomfortable symptoms in many  	women. The most common and easy to recognize symptom is hot flashes - sudden  	intense waves of heat and sweating. Some women find that these hot flashes  	disrupt their sleep, and others report mood changes. Other symptoms may  	include irregular periods, vaginal or urinary tract infections, urinary  	incontinence (leakage of urine or inability to control urine flow), and  	inflammation of the vagina. 
 	Because of the changes in the urinary tract and vagina, some women may have  	discomfort or pain during sexual intercourse. Many women also notice changes  	in their skin, digestive tract, and hair during menopause. About 75% of  	women report some troublesome symptoms during menopause. In the long term,  	some women experience problems related to the low levels of estrogen found  	after menopause. 
 	These problems include osteoporosis and increased risk for heart disease.  	The period of time leading up to menopause is often characterized by  	irregular periods. In fact, changes such as shorter or longer periods,  	heavier or lighter menstrual bleeding, and varying lengths of time between  	periods may be a sign that menopause is near. Estrogen is also now known to  	be important in memory and the healthy functioning of nerve cells in the  	brain. 
 	Some studies have shown that estrogen replacement therapy can preserve brain  	activity and even improve memory. Treatment of menopausal women with  	replacement hormones such as can slow the rate of bone thinning and may  	prevent bones from breaking. In addition, it is important that women take in  	enough calcium in their diet to strengthen the bones. 
 	Calcium is naturally found in many foods, including dairy products, and may  	also be added to a food (for instance, some orange juices now have calcium  	added). Calcium tablets are another good way to add to calcium to your diet.  	The goal should be to reach a total daily intake of 1000 milligrams per day  	before menopause or 1500 milligrams per day after menopause. 
 	Regular weight-bearing exercise, like walking, may also help prevent  	osteoporosis. Finally, the rate of heart disease rises considerably in women  	after menopause, an increase that can be prevented by estrogen replacement.  	Some experts believe that estrogen replacement therapy may be the single  	most important factor in preventing heart disease in women.
 	Premenstrual syndrome (PMS) occurs in approximately 5-10% of reproductive  	age women. They experience a variety of emotional symptoms each month during  	the second half of their menstrual cycle. While the exact cause of PMS is  	not known, clearly it is related to hormonal fluctuations. The objective of  	treatment is to make the patient more comfortable and enable her to function  	more normally.
Behavioral symptoms:
fatigue
irritability
anxiety
depression
insomnia
difficulty in working effectively
Physical symptoms:
bloating
breast tenderness
ankle swelling
headaches
acne
Treatment for PMS is quite varied. In some patients, simple life-style changes such as a diet and exercise program and stress management strategies may be extremely helpful. Decreasing caffeine and salt intake may decrease some physical symptoms. In other patients, hormonal treatments and even anti-depressant medications may be required to help the woman throught the most difficult days. Overall, the majority of women experience considerable improvement with appropriate treatment.
 	Infertility is the failure of a couple to conceive after one year of having  	regular, unprotected sexual intercourse. In women over the age of 35, it is  	often prudent to begin an evaluation of the couple after only 6 months.  	Nearly one in five couples experience infertility and seek treatment. There  	is a natural decline in fertility that comes with aging. This decline occurs  	more quickly after age 30. Primary infertility describes a couple who has  	never conceived, while secondary infertility refers to a couple who has  	achieved a pregnancy in the past but is unable to do so again. There are  	some differences in their evaluation and treatment, since theoretically, a  	couple who previously achieved a pregnancy had all the basic components of  	their reproductive systems intact. This implies a much greater likelihood  	that one or both partners have recently developed a problem that is  	responsible for their current infertility.
 	Miscarriage occurs in 15 to 25% of pregnancies. The rate of miscarriage risk  	increases markedly when a woman passes the age of 40, in some studies,  	approaching 50%. Most miscarriages are due to chromosomal abnormalities, but  	other causes may be related to anatomic, hormonal, infectious, or  	immunological abnormalities. Spontaneous abortion is the technical name for  	miscarriage. Recurrent miscarriage is usually defined as at least three  	miscarriages with no more than one pregnancy extending into the third  	trimester. When a couple presents with this history, the physician attempts  	to identify any abnormalities that may be causing the frequent losses. A  	direct cause is found less than half the time these evaluations are  	performed. 
 	Fortunately, couples with such unexplained recurrent miscarriage usually  	have a high chance of a successful subsequent pregnancy. If the woman does  	get treated for recurrent miscarriage and subsequently gets pregnant, it is  	difficult to know whether the treatment was responsible for the pregnancy's  	success. Unfortunately, few studies have been well done on this subject, and  	many of the suggested treatments are expensive and experimental. Common  	tests performed on a couple who have experienced recurrent miscarriages  	include checking their chromosomes (karyotypes), checking a woman's uterine  	anatomy (hysterosalpingogram), evaluating common hormonal problems (thyroid,  	prolactin, glucose), checking for infections (chlamydia and mycoplasma), and  	checking for common immunologic problems (antibody testing). Treatment can  	often be simple, ranging from taking a baby aspirin each day or undergoing  	an out-patient surgical procedure to remove a fibroid (hysteroscopic  	myomectomy), to more complicated immunotherapy.
 	Prolactin is a hormone occassionally overproduced by the brain, interfering  	with normal reproductive function 
Hyperprolactinemia  	
 	Prolactin is a hormone secreted by the pituitary gland (located at the base  	of the brain). Normally, prolactin is present in the blood stream in low  	levels inf nonpregnant women. During pregnancy, prolactin levels increase  	approximately ten-fold and stimulate milk formation. Hyperprolactinemia is a  	condition in the brain secretes too much prolactin in a woman who is not  	pregnant. Hyperprolactinemia can produce a variety of reproductive  	dysfunctions including inadequate progesterone production during the luteal  	phase after ovulation, irregular ovulation and menstruation, absence of  	menstruation, and galactorrhea (breast milk production by a woman who is not  	nursing). Prolactin levels should be measured in women who experience these  	conditions. Prolactin secretion may increase mildly with sleep, stress,  	intercourse, exercise, nipple stimulation, ingestion of certain foods and  	drugs, and pregnancy. If a woman's prolactin level is elevated the first  	time it is tested, a second sample should be checked when she is fasting and  	non-stressed. If the prolactin level continues to be markedly elevated, it  	is important to look for a cause. Confirmed elevations of prolactin need to  	be evaluated. In some cases, magnetic resonance imaging (MRI) or  	computerized tomography (CT) of the brain will be performed to look for  	small tumors. Low thyroid hormone production is a common medical condition  	that can cause hyperprolactinemia. In approximately 30 percent of cases, the  	hyperprolactinemia is unexplained. Parlodel and Dostinex are the two drugs  	commonly used to treat prolactin excess. They both work by suppressing  	prolactin production. Ovulation and menstruation generally return within six  	weeks of normalizing prolactin levels. Galactorrhea takes more time and is  	less certain to resolve. The side effects of these medications (including  	lightheadedness, nausea, and headache) usually resolve within the first  	month of use. Hyperprolactinemia is a common problem found in up to  	one-third of patients with absence of menstruation and in up to 90 percent  	of women with galactorrhea. Observation and expectant management is  	appropriate for some of these women, and medical management is highly  	successful in others.
 	The polycystic ovary syndrome (PCOS) is a condition in which the ovaries  	accumulate tiny cysts' (actually little follicles, two to five millimetres  	in diameter, each of which contains an egg) instead of the follicles growing  	and going on to ovulate they stall and secrete male hormone into the blood.  	Ovulation can be rare without the help of medications. In some women, there  	will be a long history of irregular periods and, perhaps, an increase in  	facial and body hair caused by more than the normal amount of male hormone  	in the blood. There are estimates that about 20 percent of all women have  	mild polycystic ovaries (PCO). It's probably genetic - often coming down the  	male side of the family. When a woman is not trying to get pregnant, oral  	contraceptive pills are good treatments: they stop follicles and  	male-hormone-producing tissue from accumulating, stops complications such as  	abnormal hair growth from taking place, gives regular periods, provides  	contraception, and protects future fertility. 
 	If you are attempting pregnancy then the drug clomiphene (Clomid) is the  	first choice to induce ovulation. If clomiphene doesn't work then physicians  	often use injectable medications such as Pergonal, Humegon, Gonal-F ,  	Follistim, and Repronex. Using hMG to induce ovulation in preparation for  	getting pregnant naturally is often complicated, however it is most  	challenging in women with PCO, since often up to 10 or 20 follicles will  	respond and try to ovulate. It is important that if this happens, the cycle  	be cancelled, and the next month be started with lower doses of medications.
 	Laparoscopy, hysteroscopy, laparotomy, and other surgeries used to evaluate  	and treat diseases of the female reproductive tract. 
 	Certain diseases require surgery for correction. Often times, the treatment  	of abnormalities of the uterus, ovaries, and fallopian tubes can be  	performed safely as an out-patient or "same-day" surgical procedure. It is  	important that your physician have advanced training and extensive  	experience in performing laparoscopic and hysteroscopic surgery to make your  	surgery safe, convenient, and minimally invasive. Other pelvic surgeries  	such as myomectomies, laparoscopically-assisted vaginal hysterectomies, and  	endometrial ablations also require significant surgical expertise.
Endometriosis is a condition in which there is a growth of tissues outside  	of the uterus that can either cause pelvic pain or infertility. It is  	without question one of the most baffling conditions that affect women. An  	estimated 10 million women in the US are affected by this disease, and it is  	one of the leading causes of infertility in women. Though there are many  	effective treatments, there is no known cure. The diagnosis is confirmed  	when uterine or endometrial cells are identified outside their usual  	location inside the uterus. 
 	Endometriosis may be found on the outside of the uterus, inside and outside  	the ovaries, or implanted upon the fallopian tubes, bowel, urinary tract,  	and anywhere in the abdomen. When a woman gets her period the endometriosis  	often responds to the menstrual cycle's hormonal signals. When the  	endometriosis bleeds, the woman may have sensations of deep pain or  	cramping. The body responds to the bleeding by surrounding it with  	inflammation often causing adhesions and leaving scar tissue. Endometriosis  	is estimated to be present in 15% of all reproductive age women, but as many  	as 30-40% of all infertile women. The exact ways that endometriosis affects  	infertility are not fully understood. Scar tissue and adhesions are known to  	interfere with the path the egg and sperm must travel to unite and become  	fertilized and implanted. In some women, endometriomas (a special type of  	ovarian cyst that contain endometrial cells that grow and bleed during  	menstruation) may form inside the ovaries causing enlargement of the  	ovaries, therefore interfering with normal ovarian functions such as  	ovulation. There also may be links between endometriosis and hormonal  	imbalances or immune system abnormalities that can also interfere with  	fertility. Some women with endometriosis experience severe pain during their  	menstrual cycle or during intercourse, excessive or irregular bleeding  	during menstruation, or urinary or bowel problems in conjunction with  	menstruation. 
 	Other symptoms may include fatigue; painful bowel movements with periods;  	lower back pain with periods; diarrhea and/or constipation and other  	intestinal upset with periods. The amount of pain is not necessarily related  	to the extent or size of growths. Other women experience no symptoms, and  	their endometriosis goes undiagnosed until they seek medical help to explain  	their inability to conceive. Because endometriosis is progressive, the key  	to preserving fertility in women who have endometriosis is early diagnosis  	and treatment of the symptoms that interfere with conception and pregnancy. 	
 	Ultrasound scans may detect the presence of endometriomas in the ovaries,  	while laparoscopy is typically the definitive way endometriosis is  	diagnosed. Laparoscopy is typically performed as an outpatient surgical  	procedure in which a fiberoptic telescope is inserted into a female's  	abdomen below the navel to look for endometriosis, scarring, and adhesions.  	While there is no known cure for this disease, effective treatment of the  	symptoms is available. In general, surgery and hormonal treatments may be  	helpful for the treatment of pain related to endometriosis. For infertility,  	there may be a need for other types of treatment following surgery to  	increase the number of eggs ovulated in a given month. In extreme cases, in  	which the endometriosis has caused extreme tubal damage, in vitro  	fertilization may be needed to bypass the scarred Fallopian tubes.    	
Uterine fibroids are benign tumors of the uterus that can cause infertility,  	heavy periods, severe menstrual cramps, and pelvic pressure. These abnormal  	growths are among of the most common causes of infertility in women. There  	are no known causes for uterine fibroids, though the explanation appears to  	be an absence of a signal to turn off division of the muscle cells that make  	up the walls of the uterus. While traditionally hysterectomy has been  	recommended for women with fibroids, women with fibroid tumors are now being  	offered more conservative treatments such as myomectomies. A myomectomy is a  	surgical procedure in which the fibroid tumor is removed, yet the uterus is  	left in place. Reconstruction of the uterus is a vital part of this  	procedure. Specialists who perform myomectomies are often able to save a  	woman from needing a hysterectomy, enabling her to retain her child-bearing  	ability. For some fibroids, the myomectomy can be done on an out-patient  	basis (laparoscopically or hysteroscopically). Medications are another  	option for treating fibroid tumors in some women. Prescription medications  	are available that can shrink the size of the fibroid and lessen heavy  	bleeding and pain. These medications can only be used for a limited period  	of time, however, and require careful monitoring by a physician.
  
 	Patients who have undergone previous tubal sterilization are candidates for  	either tubal reconstructive surgery or IVF. The most ideal candidates for  	tubal reconnection are women in whom investigations reveal that the  	subsequent total tubal length following reconnection will be greater 4 cm.,  	and cases where the tubes have been divided relatively close to the uterus.  	The statistical chance of ideal candidates for microsurgical tubal  	reconnection subsequently becoming pregnant within two years is in the range  	of 60-75 percent with a subsequent ectopic pregnancy incidence of about 10  	percent.
2-3%  	of all pregnancies occur outside of the uterus, and are called ectopic  	pregnancies. The majority of these occur in the Fallopian tubes, and can be  	life threatening if not treated. Traditional treatment included removal of  	the entire fallopian tube. More recently, these tubal pregnancies have been  	managed conservatively, either by laparoscopic surgery or by medical  	treatment (Methotrexate). Any infertility patient with abnormal bleeding and  	pelvic pain should consider ectopic pregnancy as a real possibility, and  	should have a pregnancy test performed. 
  
 	A frequent complication of fertility treatments, multiple pregnancies may  	cause pre-term labor, pregnancy-induced hypertension, and diabetes. Early  	diagnosis is vital in order to provide preventative care, and explore all  	medical options, including multifetal reduction in cases of higher order  	multiple gestations (triplets, quadruplets, etc.). The key to the treatment  	of multiple pregnancies is to avoid their occurrence by carefully monitoring  	patients receiving fertility drugs, and minimizing the embryos transferred  	in patients undergoing in vitro fertilization.
 	Overgrowths of the uterine lining are called endometrial polyps. Some polyps  	are found incidentally, and do not require treatment. Others may cause  	irregular bleeding, and, at times, infertility, and should be surgically  	removed. When performed by an experienced surgeon, the treatment of  	endometrial polyps can be performed hysteroscopically as an out-patient  	procedure, and should be safe and effective.
Traditional methods used to identify genetic disease require prenatal diagnosis through amniocentesis or CVS, followed by potential termination of the pregnancy if the fetus is found to be affected. Recent scientific advances now allow the diagnosis of some genetic disorders before pregnancy is established using a technique known as PGD. PGD combines the technology of in-vitro fertilization (IVF) with new molecular biology techniques. Following fertilization of an egg, a single cell is removed from an embryo in a procedure called an "embryo biopsy." If the embryo is found not to contain the genetic disorder being tested for, the embryo is transferred into the uterus, and allowed to develop. Couples with a known genetic disorders can now have unaffected children without the emotional and ethical challenges associated with traditional prenatal diagnosis.
References:
Reprinted with permission of 
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.




















